BCHE and Alzheimer disease: Earlier investigations reported that donepezil-treated male AD patients performed better in the Boston Naming Test than females (Davis and Barrett, 2009), supporting earlier findings that reported greater efficacy of cholinesterase inhibitors in male AD patients (MacGowan et al., 1998).